Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Retatrutide is an investigational triple agonist peptide currently under clinical development, targeting the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors simultaneously
Dosing and Administration Both medications are typically administered as a once-weekly injection
The COA should reference a specific batch or lot number that matches the product you receive
The half-life refers to the time it takes for the concentration of a substance to reduce by half in the body
From these studies, it is possible to identify the types of individuals who may be more likely to respond to ALCAR
"The same active ingredient doesn't guarantee the same therapeutic outcome when manufacturing standards and quality controls differ significantly." Pharmaceutical Quality Research, 2024 1
US$ 26.33
US$ 22.91
US$ 22.16
